Tal Lorberbaum
Cited by
Cited by
Similarity-based modeling in large-scale prediction of drug-drug interactions
S Vilar, E Uriarte, L Santana, T Lorberbaum, G Hripcsak, C Friedman, ...
Nature protocols 9 (9), 2147-2163, 2014
Coupling data mining and laboratory experiments to discover drug interactions causing QT prolongation
T Lorberbaum, KJ Sampson, JB Chang, V Iyer, RL Woosley, RS Kass, ...
Journal of the American College of Cardiology 68 (16), 1756-1764, 2016
Disease heritability inferred from familial relationships reported in medical records
FCG Polubriaginof, R Vanguri, K Quinnies, GM Belbin, A Yahi, ...
Cell 173 (7), 1692-1704. e11, 2018
Systems biology approaches for identifying adverse drug reactions and elucidating their underlying biological mechanisms
MR Boland*, A Jacunski*, T Lorberbaum*, JD Romano, R Moskovitch, ...
Wiley Interdisciplinary Reviews: Systems Biology and Medicine, 2015
An integrative data science pipeline to identify novel drug interactions that prolong the QT interval
T Lorberbaum, KJ Sampson, RL Woosley, RS Kass, NP Tatonetti
Drug safety 39 (5), 433-441, 2016
Systems pharmacology augments drug safety surveillance
T Lorberbaum, M Nasir, MJ Keiser, S Vilar, G Hripcsak, NP Tatonetti
Clinical Pharmacology & Therapeutics 97 (2), 151-158, 2015
A computational drug repositioning approach for targeting oncogenic transcription factors
KM Gayvert, E Dardenne, C Cheung, MR Boland, T Lorberbaum, ...
Cell reports 15 (11), 2348-2356, 2016
Improving detection of arrhythmia drug-drug interactions in pharmacovigilance data through the implementation of similarity-based modeling
S Vilar, T Lorberbaum, G Hripcsak, NP Tatonetti
PloS one 10 (6), e0129974, 2015
Estimate of disease heritability using 7.4 million familial relationships inferred from electronic health records
F Polubriaginof, R Vanguri, K Quinnies, GM Belbin, A Yahi, H Salmasian, ...
Large-scale adverse effects related to treatment evidence standardization (LAERTES): an open scalable system for linking pharmacovigilance evidence sources with clinical data
RD Boyce, EA Voss, V Huser, L Evans, C Reich, JD Duke, NP Tatonetti, ...
Journal of Biomedical Semantics 8 (11), 2017
Comparative analysis, applications, and interpretation of electronic health record-based stroke phenotyping methods
PM Thangaraj, BR Kummer, T Lorberbaum, MSV Elkind, NP Tatonetti
BioData mining 13 (1), 1-14, 2020
Predicting the genetic ancestry of 2.6 million New York City patients using clinical data
V Ramlall, KM Quinnies, R Vanguri, T Lorberbaum, DB Goldstein, ...
bioRxiv, 768440, 2019
Comparative analysis of EHR-based stroke phenotyping methods, their applications, and interpretation
P Thangaraj, B Kummer, T Lorberbaum, M Elkind, N Tatonetti
bioRxiv, 565671, 2019
Reply: Combination Therapy With Ceftriaxone and Lansoprazole, Acquired Long QT Syndrome and Torsades de Pointes Risk
T Lorberbaum, NP Tatonetti
Journal of the American College of Cardiology 69 (14), 1877-1878, 2017
Discovering new drug-drug interactions using data science: Applications to drug-induced Long QT Syndrome
T Lorberbaum
Columbia University, 2017
Estimate of disease heritability using 7.4 million familial relationships inferred from
F Polubriaginof, R Vanguri, K Quinnies, GM Belbin, A Yahi, H Salmasian, ...
JAMA 315, 68-9, 2016
Improving Detection of Arrhythmia Drug-Drug Interactions in Pharmacovigilance Data through the Implementation of Similarity-Based Modeling
S Vilar Varela, T Lorberbaum, GM Hripcsak, NP Tatonetti
Improving user engagement and insight through Contextualized Quantified Self
T Callahan*, T Lorberbaum*, A Yahi*
AMIA, 2015
nSides: An interactive drug–side effect gateway
RS Vanguri, JD Romano, T Lorberbaum, C Youn, V Nwankwo, ...
The system can't perform the operation now. Try again later.
Articles 1–19